Results 61 to 70 of about 1,352,022 (283)

Revisiting JMLA case reports: a publication category for driving innovation in health sciences librarianship

open access: yesJournal of the Medical Library Association
In the April 2019 issue (Vol. 106 No. 3), the Journal of the Medical Library Association (JMLA) debuted its Case Report publication category. In the years following this decision, the Case Reports category has grown into an integral component of JMLA ...
Jill T. Boruff, AHIP   +2 more
doaj   +1 more source

Jefferson Medical College Alumni Bulletin-– Vol. 1 No. 13; January, 1930 [PDF]

open access: yes, 1930
Table of Contents – Vol. 1 No. 13; January, 1930 A Greater Jefferson, Page 1 Exercises of Dedication of the New College Building, Page 2 Alumni Clinics, Page 2 Alumni Association, Page 3 The Dedicatory Speaker, Page 3 The Foundation and the Founder of ...

core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

116th Annual Meeting Medical Library Association, Inc. Toronto, ON, Canada May 13-18, 2016

open access: yesJournal of the Medical Library Association, 2017
This is a correction to the original article. For information about the changes made, please see the correction: DOI: dx.doi.org/10.5195/jmla.2017.202.
Nicole Mitchell
doaj   +1 more source

Wandering the Web -- To Your Good Health: Health Websites for Parents, Teens, and Kids [PDF]

open access: yes, 2010
Parents, children, and teens are frequent users of health information on the Web. The Medical Library Association, the HONcode designation, and a checklist of quality indicators can be used to find and evaluate information on the Web.
Watwood, Carol L.
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Jefferson Medical College Alumni Bulletin–Vol. 2 No. 7 May, 1940 [PDF]

open access: yes, 1940
Table of contents – Vol. 2 No. 7 May, 1940 Dr. J. Parsons Schaeffer: Commemorating the Anniversary of His Twenty-Fifth Year as Professor of Anatomy, Page 1 Anatomy in the Modern Medical School, Page 2 Daniel Baugh Institute of Anatomy, Page 4 The ...

core   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Special Libraries, May-June 1957 [PDF]

open access: yes, 1956
Volume 48, Issue 5https://scholarworks.sjsu.edu/sla_sl_1957/1004/thumbnail ...
Special Libraries Association
core   +2 more sources

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy